166 related articles for article (PubMed ID: 19527068)
1. NMR and computational studies of stereoisomeric equine estrogen-derived DNA cytidine adducts in oligonucleotide duplexes: opposite orientations of diastereomeric forms.
Zhang N; Ding S; Kolbanovskiy A; Shastry A; Kuzmin VA; Bolton JL; Patel DJ; Broyde S; Geacintov NE
Biochemistry; 2009 Aug; 48(30):7098-109. PubMed ID: 19527068
[TBL] [Abstract][Full Text] [Related]
2. Base selectivity and effects of sequence and DNA secondary structure on the formation of covalent adducts derived from the equine estrogen metabolite 4-hydroxyequilenin.
Kolbanovskiy A; Kuzmin V; Shastry A; Kolbanovskaya M; Chen D; Chang M; Bolton JL; Geacintov NE
Chem Res Toxicol; 2005 Nov; 18(11):1737-47. PubMed ID: 16300383
[TBL] [Abstract][Full Text] [Related]
3. 4-hydroxyequilenin-adenine lesions in DNA duplexes: stereochemistry, damage site, and structure.
Ding S; Shapiro R; Geacintov NE; Broyde S
Biochemistry; 2007 Jan; 46(1):182-91. PubMed ID: 17198388
[TBL] [Abstract][Full Text] [Related]
4. Equilenin-derived DNA adducts to cytosine in DNA duplexes: structures and thermodynamics.
Ding S; Shapiro R; Geacintov NE; Broyde S
Biochemistry; 2005 Nov; 44(44):14565-76. PubMed ID: 16262256
[TBL] [Abstract][Full Text] [Related]
5. Conformations of stereoisomeric base adducts to 4-hydroxyequilenin.
Ding S; Shapiro R; Geacintov NE; Broyde S
Chem Res Toxicol; 2003 Jun; 16(6):695-707. PubMed ID: 12807352
[TBL] [Abstract][Full Text] [Related]
6. Conformational properties of equilenin-DNA adducts: stereoisomer and base effects.
Ding S; Shapiro R; Cai Y; Geacintov NE; Broyde S
Chem Res Toxicol; 2008 May; 21(5):1064-73. PubMed ID: 18416538
[TBL] [Abstract][Full Text] [Related]
7. Translesion synthesis past equine estrogen-derived 2'-deoxycytidine DNA adducts by human DNA polymerases eta and kappa.
Suzuki N; Yasui M; Santosh Laxmi YR; Ohmori H; Hanaoka F; Shibutani S
Biochemistry; 2004 Sep; 43(35):11312-20. PubMed ID: 15366941
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glutathione S-transferase activity by the quinoid metabolites of equine estrogens.
Chang M; Zhang F; Shen L; Pauss N; Alam I; van Breemen RB; Blond SY; Bolton JL
Chem Res Toxicol; 1998 Jul; 11(7):758-65. PubMed ID: 9671538
[TBL] [Abstract][Full Text] [Related]
9. The major metabolite of equilin, 4-hydroxyequilin, autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone.
Zhang F; Chen Y; Pisha E; Shen L; Xiong Y; van Breemen RB; Bolton JL
Chem Res Toxicol; 1999 Feb; 12(2):204-13. PubMed ID: 10027800
[TBL] [Abstract][Full Text] [Related]
10. Development of a liquid chromatography electrospray ionization tandem mass spectrometry method for analysis of stable 4-hydroxyequilenin-DNA adducts in human breast cancer cells.
Wang Z; Edirisinghe P; Sohn J; Qin Z; Geacintov NE; Thatcher GR; Bolton JL
Chem Res Toxicol; 2009 Jun; 22(6):1129-36. PubMed ID: 19368368
[TBL] [Abstract][Full Text] [Related]
11. Determination of absolute configurations of 4-hydroxyequilenin-cytosine and -adenine adducts by optical rotatory dispersion, electronic circular dichroism, density functional theory calculations, and mass spectrometry.
Ding S; Wang Y; Kolbanovskiy A; Durandin A; Bolton JL; van Breemen RB; Broyde S; Geacintov NE
Chem Res Toxicol; 2008 Sep; 21(9):1739-48. PubMed ID: 18680315
[TBL] [Abstract][Full Text] [Related]
12. Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro.
Pisha E; Lui X; Constantinou AI; Bolton JL
Chem Res Toxicol; 2001 Jan; 14(1):82-90. PubMed ID: 11170511
[TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of 4-hydroxyequilenin-DNA adducts in mammalian cells using an immunoassay with a novel monoclonal antibody.
Okahashi Y; Iwamoto T; Suzuki N; Shibutani S; Sugiura S; Itoh S; Nishiwaki T; Ueno S; Mori T
Nucleic Acids Res; 2010 Jul; 38(12):e133. PubMed ID: 20406772
[TBL] [Abstract][Full Text] [Related]
14. A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines.
Chen Y; Liu X; Pisha E; Constantinou AI; Hua Y; Shen L; van Breemen RB; Elguindi EC; Blond SY; Zhang F; Bolton JL
Chem Res Toxicol; 2000 May; 13(5):342-50. PubMed ID: 10813650
[TBL] [Abstract][Full Text] [Related]
15. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.
Yao J; Li Y; Chang M; Wu H; Yang X; Goodman JE; Liu X; Liu H; Mesecar AD; Van Breemen RB; Yager JD; Bolton JL
Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597
[TBL] [Abstract][Full Text] [Related]
16. Translesion synthesis past equine estrogen-derived 2'-deoxyadenosine DNA adducts by human DNA polymerases eta and kappa.
Yasui M; Laxmi YR; Ananthoju SR; Suzuki N; Kim SY; Shibutani S
Biochemistry; 2006 May; 45(19):6187-94. PubMed ID: 16681391
[TBL] [Abstract][Full Text] [Related]
17. Alkylation of 2'-deoxynucleosides and DNA by the Premarin metabolite 4-hydroxyequilenin semiquinone radical.
Shen L; Qiu S; Chen Y; Zhang F; van Breemen RB; Nikolic D; Bolton JL
Chem Res Toxicol; 1998 Feb; 11(2):94-101. PubMed ID: 9511900
[TBL] [Abstract][Full Text] [Related]
18. Conformational analysis of a 4-hydroxyequilenin Guanine adduct using density functional theory.
Yan S; Wu M; Ding S; Geacintov NE; Broyde S
Chem Res Toxicol; 2002 May; 15(5):648-53. PubMed ID: 12018985
[TBL] [Abstract][Full Text] [Related]
19. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove.
Cosman M; Hingerty BE; Luneva N; Amin S; Geacintov NE; Broyde S; Patel DJ
Biochemistry; 1996 Jul; 35(30):9850-63. PubMed ID: 8703959
[TBL] [Abstract][Full Text] [Related]
20. Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens.
Wang Z; Chandrasena ER; Yuan Y; Peng KW; van Breemen RB; Thatcher GR; Bolton JL
Chem Res Toxicol; 2010 Aug; 23(8):1365-73. PubMed ID: 20509668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]